The information available and accessible below is disclosed in accordance with AIM Rule 26. This information was last updated on 8 December 2023.
Country of Incorporation and Main Country of Operation
Poolbeg Pharma Plc is incorporated and registered in England and Wales and its main country of operation is the UK.
Total Shares in Issue
500,000,000
Shareholdings
| Significant Shareholders | Shares | % |
|---|---|---|
| Cathal Friel | 36,389,757 | 7.28% |
| Schroders PLC | 24,994,777 | 4.99% |
| Michael Kelly | 18,168,127 | 3.63% |
| Directors Shareholding | Shares | % |
|---|---|---|
| Cathal Friel | 36,389,757 | 7.28% |
| Jeremy Skillington | 718,733 | 0.14% |
| Ian O’Connell | 8,326,839 | 1.67% |
| Brendan Buckley | 2,631,474 | 0.53% |
Shares Not in Public Hands
Pursuant to the AIM rules, and insofar as it is aware, at 7 December 2023, 9.61% of the Company’s securities were not in public hands. There are no shares held in treasury.
Securities Information
The Company is subject to the UK City Code on Takeovers and Mergers.
There are no restrictions on the transfer of ordinary shares.
The shares of the Company are traded on the AIM market operated by the London Stock Exchange.
Company Secretary
Beach Secretaries Limited
Company Registration Number
13279507
International Securities Identification Number (ISIN)
GB00BKPG7Z60
